ZA969285B - NK-1 receptor antagonists for the treatment of cancer. - Google Patents

NK-1 receptor antagonists for the treatment of cancer.

Info

Publication number
ZA969285B
ZA969285B ZA9609285A ZA969285A ZA969285B ZA 969285 B ZA969285 B ZA 969285B ZA 9609285 A ZA9609285 A ZA 9609285A ZA 969285 A ZA969285 A ZA 969285A ZA 969285 B ZA969285 B ZA 969285B
Authority
ZA
South Africa
Prior art keywords
cancer
treatment
receptor antagonists
antagonists
receptor
Prior art date
Application number
ZA9609285A
Inventor
Harry R Howard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA969285B publication Critical patent/ZA969285B/en

Links

ZA9609285A 1995-11-06 1996-11-05 NK-1 receptor antagonists for the treatment of cancer. ZA969285B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US727595P 1995-11-06 1995-11-06

Publications (1)

Publication Number Publication Date
ZA969285B true ZA969285B (en) 1998-05-05

Family

ID=21725216

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9609285A ZA969285B (en) 1995-11-06 1996-11-05 NK-1 receptor antagonists for the treatment of cancer.

Country Status (1)

Country Link
ZA (1) ZA969285B (en)

Similar Documents

Publication Publication Date Title
AU3642795A (en) Endothelin receptor antagonists for the treatment of emesis
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
EP0676959A4 (en) Endothelin receptor antagonists.
HU9603525D0 (en) Vironectin receptor antagonists
ZA9610854B (en) Vitronectin receptor antagonists.
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
ZA9610859B (en) Vitronectin receptor antagonists.
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
ZA9610855B (en) Vitronectin receptor antagonists.
ZA9711090B (en) Process for the preparation of hydrocarbons.
ZA969775B (en) Endothelin receptor antagonists.
HU9600256D0 (en) Substituted diphenyl-sulfonamides, antagonists of endothelin
ZA9710322B (en) Process for the preparation of benzyl-ethers.
DE69628446D1 (en) Polycarbonatharz, vernetztes polycarbonatharz und elektrophotographischer photorezeptor
HU9601176D0 (en) Adhesion-receptor antagonists
ZA952587B (en) Human tumor necrosis factor receptor
EP0853629A4 (en) Hepadnavirus receptor
ZA973209B (en) Therapeutic compounds.
EP0666851A4 (en) Substituted phthalazinones as nerotensin antagonists.
GB9517098D0 (en) Receptor
AU7059296A (en) NK-1 receptor antagonists for the treatment of cancer
ZA974811B (en) Novel therapeutic compounds.
ZA979151B (en) Pyrazolinones for treating impaired potency.
ZA965494B (en) Therapeutic agents.
ZA966552B (en) Endothelin receptor antagonists.